NCT05011838 is a NA clinical trial of 1. Health Services Redesign in Hypertension, sponsored by Institute of Tropical Medicine, Belgium.

Who is sponsoring NCT05011838?

NCT05011838 is sponsored by Institute of Tropical Medicine, Belgium.

What drugs are being tested in NCT05011838?

Interventions in NCT05011838: 1. Health Services Redesign, 2. Clinical Staff Training, 3. Patient and Community Engagement.

What condition does NCT05011838 study?

NCT05011838 studies Hypertension.

Is NCT05011838 still recruiting?

NCT05011838 is currently withdrawn. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT05011838

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effectiveness of an Intervention to Reduce Gaps in Hypertension Care in Low-income Medellin, Colombia

Withdrawn NA Last updated 12 March 2024

What this trial tests

NA trial testing 1. Health Services Redesign in Hypertension. Withdrawn.

Timeline

14 February 2023

Primary endpoint
14 February 2025

18 October 2026

Quick facts

Lead sponsor	Institute of Tropical Medicine, Belgium
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	health services research
Start date	14 February 2023
Primary completion	14 February 2025
Estimated completion	18 October 2026
Sites	1 location across Colombia

Drugs / interventions tested

1. Health Services Redesign
2. Clinical Staff Training
3. Patient and Community Engagement

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

Institute of Tropical Medicine, Belgium

Who can join

35 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effectiveness of a multi-component intervention to reduce the gaps in hypertension care and control at a population level in low-income Communes of Medellin, Colombia, and assess the process and fidelity of the intervention's implementation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Protocol for a controlled before-after quasi-experimental study to evaluate the effectiveness of a multi-component intervention to reduce gaps in hypertension care and control in low-income communes of Medellin, Colombia.
Londoño Agudelo EA, Battaglioli T, Soto A, Vásquez Gómez J, et al · · 2022 · cited 3× · PMID 36002215 · DOI 10.1136/bmjopen-2021-056262
The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review.
Molina de Salazar DI, Coca A, Alcocer L, Piskorz D. · · 2024 · cited 2× · PMID 38489104 · DOI 10.1007/s40256-024-00634-8

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Institute of Tropical Medicine, Belgium trials

Trials by the same sponsor.

NCT07463040 — Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) · Phase 3 · not yet recruiting
NCT07174648 — Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo. · not yet recruiting
NCT07499739 — Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX) · Phase 4 · not yet recruiting
NCT07342829 — Prospective Follow-up After MVA-BN Booster Vaccination · not yet recruiting
NCT06839989 — An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05011838 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institute of Tropical Medicine, Belgium
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05011838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing